QXO Inc
QXO Inc (QXO) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for QXO Inc (QXO), featuring income statements, balance sheets, and cash flow data.
QXO Inc (QXO) Income Statement & Financial Overview
Analyze QXO Inc’s QXO earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $13.51M | $14.74M | $13.15M | $14.54M |
| Cost of Revenue | $8.12M | $8.71M | $7.71M | $8.74M |
| Gross Profit | $5.39M | $6.04M | $5.44M | $5.79M |
| Gross Profit Ratio | $0.40 | $0.41 | $0.41 | $0.40 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $44.42M | $38.90M | $39.02M | $9.84M |
| Operating Expenses | $44.67M | $39.14M | $39.27M | $10.10M |
| Total Costs & Expenses | $52.79M | $47.84M | $46.98M | $18.84M |
| Interest Income | $56.56M | $0.00 | $0.00 | $3.47M |
| Interest Expense | $6000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $278000.00 | $271000.00 | $137000.00 | $356533.00 |
| EBITDA | $17.55M | $89.04M | -$33.58M | -$4.003M |
| EBITDA Ratio | $1.30 | $6.04 | -$2.55 | -$0.28 |
| Operating Income | -$39.29M | -$33.10M | -$33.83M | -$4.30M |
| Operating Income Ratio | -$2.91 | -$2.25 | -$2.57 | -$0.30 |
| Other Income/Expenses (Net) | $56.55M | $61.37M | $56.99M | $3.47M |
| Income Before Tax | $17.27M | $28.27M | $23.16M | -$831000.00 |
| Income Before Tax Ratio | $1.28 | $1.92 | $1.76 | -$0.06 |
| Income Tax Expense | $8.51M | $16.98M | $6.03M | -$240000.00 |
| Net Income | $8.76M | $11.29M | $17.13M | -$591000.00 |
| Net Income Ratio | $0.65 | $0.77 | $1.30 | -$0.04 |
| EPS | -$0.03 | -$0.02 | -$0.01 | -$9.93 |
| Diluted EPS | -$0.03 | -$0.02 | -$0.01 | -$9.93 |
| Weighted Avg Shares Outstanding | $451.43M | $451.43M | $358.81M | $332.00M |
| Weighted Avg Shares Outstanding (Diluted) | $451.43M | $451.43M | $358.81M | $332.00M |
The company's financials show resilient growth, with revenue advancing from $14.54M in Q2 2024 to $13.51M in Q1 2025. Gross profit remained healthy with margins at 40% in Q1 2025 compared to 40% in Q2 2024. Operating income hit -$39.29M last quarter, sustaining a consistent -291% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $17.55M. Net income dropped to $8.76M, while earnings per share reached -$0.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan